Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations WAVE Q1 2026 Earnings EPS Beats Estimates by Wide Margin Stock Declines CIMP Q1 2026 Earnings EPS Beats Estimates as Mortgage REIT Maintains Stable Performance CSGP Q1 2026 Earnings Strong EPS Beat of 225 Lifts Sentiment First Citizens BancShares FCNCA Q1 2026 Earnings Strong EPS Beat Highlights Resilient Core Operations NATR Q1 2026 Earnings Strong EPS Beat Hints at Profitability Gains